Inova Blog
Partnering news & trends
Life Sciences News & Trends
Making a Billion Dollar Pharma Deal Happen
Eli Lilly & Company and Evox Therapeutics recently took Inova behind the scenes of their b...
More Deals, and Earlier
For a while now my colleagues at Inova have taken note of a pretty consistent trend in pharma partne...
Biotechs leading the way: first in inclusion, first in diversity
In a report released in January, industry group BIO explored how diverse the biopharma sector actual...
Biomedical Research and the Problem with Male-Centric Medicine
You wouldn’t buy bread from a baker who only sold to males, and you wouldn’t work for a company ...
What to Expect in Biopharma in 2020
Happy New Year!
The Holidays are behind us and it’s time to take a quick look at what’s lying...
Social media vs digital health: why are there double standards?
We live in a digital world. More than 5 billion people worldwide now have a mobile phone and over ha...
Open Innovation in Pharma: The Next Chapter
Open innovation did not come naturally to the pharma industry. While the consumer goods and manufact...
Lessons from Google – Collaboration Catalyzes Innovation in the Life Sciences
Google® is ubiquitous in the daily life of everyone using the internet. The company is synonymous w...
Collaboration in Pharma – Today’s Business Imperative
It wasn’t that long ago that the pharma giants were fierce competitors. Back then, conversations a...
How pricing is impacting oncology partnerships
A lot is happening in the field of Oncology. Cancer remains a leading cause of death, but innovative...
Genentech Partnering: Driving Success with Flexible Alliance Management
Partnering in the life sciences isn’t for the faint of heart. It’s time-consuming, subject to su...
Partnering in the Life Sciences: Collaboration vs M&A
There’s a general consensus that partnering and M&A in the life sciences enable access to exte...